Instagram Story Viewer

Heart disease can run in families and so can high Lipoprotein (a), also known as "Lp(a)" or "L-P-little a.” This inherited condition affects about 1 in 5 people in the US and is more prevalent than people may realize.

A simple blood test can measure your Lp(a) level. It’s especially important if you or a family member had an early heart event (for men, this means before age 55, and for women, before age 65).

🔗 https://novartis.social/6177vV0Lx

How can we drive awareness and prevention of breast and prostate cancer by investing in community health?

The answer? Think local. That’s why we are launching our Inclusive Health Accelerators (IHA) Program.

The goal? To help close gaps in breast and prostate cancer care through a holistic, community-first approach.

Learn more about our new model and the 4 reasons we are investing in America’s Health and our communities at 🔗 in bio.

#NovartisUS

📍 Denton, Texas

Novartis recently broke ground on our new radioligand therapy (RLT) manufacturing facility, marking the latest milestone in our $23 billion investment in US research and manufacturing.

With construction 👷 of the company's first Texas-based manufacturing facility underway, Novartis will soon have expanded US RLT production capabilities closer to patients across the southern US.

Swipe above to see a few 📸 from the event!

#NovartisUS

📍 Denton, Texas

Novartis recently broke ground on our new radioligand therapy (RLT) manufacturing facility, marking the latest milestone in our $23 billion investment in US research and manufacturing.

With construction 👷 of the company's first Texas-based manufacturing facility underway, Novartis will soon have expanded US RLT production capabilities closer to patients across the southern US.

Swipe above to see a few 📸 from the event!

#NovartisUS

📍 Denton, Texas

Novartis recently broke ground on our new radioligand therapy (RLT) manufacturing facility, marking the latest milestone in our $23 billion investment in US research and manufacturing.

With construction 👷 of the company's first Texas-based manufacturing facility underway, Novartis will soon have expanded US RLT production capabilities closer to patients across the southern US.

Swipe above to see a few 📸 from the event!

#NovartisUS

📍 Denton, Texas

Novartis recently broke ground on our new radioligand therapy (RLT) manufacturing facility, marking the latest milestone in our $23 billion investment in US research and manufacturing.

With construction 👷 of the company's first Texas-based manufacturing facility underway, Novartis will soon have expanded US RLT production capabilities closer to patients across the southern US.

Swipe above to see a few 📸 from the event!

#NovartisUS

📍 Denton, Texas

Novartis recently broke ground on our new radioligand therapy (RLT) manufacturing facility, marking the latest milestone in our $23 billion investment in US research and manufacturing.

With construction 👷 of the company's first Texas-based manufacturing facility underway, Novartis will soon have expanded US RLT production capabilities closer to patients across the southern US.

Swipe above to see a few 📸 from the event!

#NovartisUS

For 25 years, just like technology has advanced, so have the innovations that shape treatment for those living with chronic myeloid leukemia (CML).

Watch to see how Novartis continues to move this story forward through advocating for innovation, partnerships, and working with community members. 🤝

To the patients, caregivers, clinicians, researchers, and advocates who make up this community, thank you for the progress we’ve made together.

https://bit.ly/4mW5VVW

#NovartisUS

#Sponsored Making the reservation is easy. Navigating the menu?

That’s the real challenge.

For millions, food allergies are a constant part of the plan. We’re excited to partner with @NovartisUS and @Genentech to bring you "Food Allergies in the City", a new series following five friends as they navigate life, love, and the big city. Check back in soon to tune in!

Intended for US audiences only.

#FoodAllergiesInTheCity #FoodAllergies #FoodAllergyAwareness

We’re expanding radioligand therapy (RLT) manufacturing and bringing production closer to patients in the southern US.

Today, we broke ground on a new site in 📍Denton, Texas—growing the nation’s largest coast-to-coast RLT network. As part of our $23 billion US investment in research and manufacturing, this milestone marks our fifth RLT site nationwide and reflects our commitment to bringing highly personalized cancer therapies closer to patients.

Learn more at link in bio.

#NovartisUS

We’re expanding radioligand therapy (RLT) manufacturing and bringing production closer to patients in the southern US.

Today, we broke ground on a new site in 📍Denton, Texas—growing the nation’s largest coast-to-coast RLT network. As part of our $23 billion US investment in research and manufacturing, this milestone marks our fifth RLT site nationwide and reflects our commitment to bringing highly personalized cancer therapies closer to patients.

Learn more at link in bio.

#NovartisUS

We’re expanding radioligand therapy (RLT) manufacturing and bringing production closer to patients in the southern US.

Today, we broke ground on a new site in 📍Denton, Texas—growing the nation’s largest coast-to-coast RLT network. As part of our $23 billion US investment in research and manufacturing, this milestone marks our fifth RLT site nationwide and reflects our commitment to bringing highly personalized cancer therapies closer to patients.

Learn more at link in bio.

#NovartisUS

We’re expanding radioligand therapy (RLT) manufacturing and bringing production closer to patients in the southern US.

Today, we broke ground on a new site in 📍Denton, Texas—growing the nation’s largest coast-to-coast RLT network. As part of our $23 billion US investment in research and manufacturing, this milestone marks our fifth RLT site nationwide and reflects our commitment to bringing highly personalized cancer therapies closer to patients.

Learn more at link in bio.

#NovartisUS

We’re expanding radioligand therapy (RLT) manufacturing and bringing production closer to patients in the southern US.

Today, we broke ground on a new site in 📍Denton, Texas—growing the nation’s largest coast-to-coast RLT network. As part of our $23 billion US investment in research and manufacturing, this milestone marks our fifth RLT site nationwide and reflects our commitment to bringing highly personalized cancer therapies closer to patients.

Learn more at link in bio.

#NovartisUS

NFL legend Lynn Swann and fans turned out at the NFL Draft experience for their PSA blood test at the Crucial Catch Community Screening event sponsored by Novartis. Don’t sit on the sidelines when it comes to your health. Comment ‘Catch’ to find your local cancer screening center.

From coast to coast, we’re expanding our US manufacturing and research footprint. Through our $23 billion commitment, we are dedicated to ensuring all key medicines for US patients are produced in the US. We’re delivering on our commitment by:

✅ Expanding end-to-end production in the US across our four key therapeutic areas

✅ Creating the largest coast-to-coast radioligand therapy (RLT) manufacturing network

✅ Investing in our workforce to strengthen communities

Learn more about our investment and work at 🔗 in bio.

#NovartisUS

People living with #Sjogrens disease, a serious autoimmune condition that can affect the entire body, too often find their symptoms overlooked or downplayed.

At Novartis, we’re committed to changing that. We're proud to partner with TV personality and Sjögren's advocate @CarrieAnnInaba, who has lived with Sjögren’s for over a decade and understands how deeply this disease can affect someone's life. She's lending her voice to help people living with Sjögren's find theirs so they can advocate for themselves and get the care they deserve.

Are you ready to #SJOUT with us? Stay tuned for more from Carrie Ann and in the meantime, visit SjoutForSjogrens.com for helpful resources.

#SjogrensAwarenessMonth #SjoutForSjogrens

Their earlier version of themselves would be proud.

Today we’re celebrating four Novartis colleagues recognized by the Healthcare Businesswomen’s Association (HBA) for their leadership and impact in healthcare.

✨Rising Stars: Amrita G. Sawhney, MD
Martina Scionti

✨Luminary Honorees:
Ashley Duff
Rachel Morgan

From childhood dreams to shaping the future of medicine — congratulations on this well deserved recognition!

#NovartisUS #AscendWithHBA #HBAAwards

Early breast cancer detection saves lives—but cost can still stand in the way.

That’s why we continue calling for affordable coverage of follow-up diagnostics as we mark one year of collaboration with @susangkomen and the Alliance for Breast Cancer Policy.

Together with our team members and advocacy partners, we’re working toward a future where no one faces financial barriers to the answers and care they need.

#NovartisUS #AllianceForBreastCancerPolicy #BreastCancer

Early breast cancer detection saves lives—but cost can still stand in the way.

That’s why we continue calling for affordable coverage of follow-up diagnostics as we mark one year of collaboration with @susangkomen and the Alliance for Breast Cancer Policy.

Together with our team members and advocacy partners, we’re working toward a future where no one faces financial barriers to the answers and care they need.

#NovartisUS #AllianceForBreastCancerPolicy #BreastCancer

Early breast cancer detection saves lives—but cost can still stand in the way.

That’s why we continue calling for affordable coverage of follow-up diagnostics as we mark one year of collaboration with @susangkomen and the Alliance for Breast Cancer Policy.

Together with our team members and advocacy partners, we’re working toward a future where no one faces financial barriers to the answers and care they need.

#NovartisUS #AllianceForBreastCancerPolicy #BreastCancer

How can knowing your Lp(a) level be an important step in understanding your overall heart health? 🫀

For Susan who had a heart attack at a younger age (this means having a heart attack before age 55 for men and before age 65 for women), knowing her Lp(a) level helped her and her care team better understand and manage her overall heart health.

Learn more about Susan’s experience: 🔗 https://go.novartis.social/4tax8Gu

If you’ve had an early heart event or have a family history of early heart events, ask your health care provider about testing for Lp(a). It’s a simple blood test.

Lp(a): L-P-little a, Lipoprotein (a).

#NovartisUS #lpaawareness #KnowLpa